Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Viscosupplementation for Early Knee Degenerative Pathology
NCT02135367Completed
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- Jan 2013
- Primary completion
- Apr 2018
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised, double-blind trial of platelet-rich plasma in knee osteoarthritis (OA) and chondropathy, sponsored by Istituto Ortopedico Rizzoli. Primary endpoint: International Knee Documentation Committee subjective score at 12 months. Started Jan 2013; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)chondropathy
Beyond the preview
Go deeper on NCT02135367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135367.